Health Care Utilization and Costs in Systemic Therapies for Metastatic Melanoma from 2016 to 2020

By sjmartinez • October 28, 2022

Qian MF, Betancourt NJ, Pineda A, Maloney NJ, Nguyen KA, Reddy SA, Hall ET, Swetter SM, Zaba LC. Health Care Utilization and Costs in Systemic Therapies for Metastatic Melanoma from 2016 to 2020. Oncologist. 2022 Oct 27:oyac219. doi: 10.1093/oncolo/oyac219. Epub ahead of print. PMID: 36302223.

Tags: administrative claims, Dermatology, healthcare, Healthcare cost, immune checkpoint inhibitors, melanoma, molecular targeted therapy, Publications

MicroBayesAge: a maximum likelihood approach to predict epigenetic age using microarray data

Nolan N, Mitchell M, Mboning L, Bouchard LS, Pellegrini M. MicroBayesAge: a maximum likelihood approach to predict epigenetic age using microarray data. Geroscience. 2025 May[...]

Characterization of IgE cross-reactivity and allergenicity of peanut allergens

Lapitan C, Zhang WR, Guo B, Daniels-Wells TR, Penichet ML, Zhang K. Characterization of IgE cross-reactivity and allergenicity of peanut allergens. Immunohorizons. 2025 May 30;9(7):vlaf018.[...]

Deucravacitinib in Patients with Plaque Psoriasis Who Screened Positive for Psoriatic Arthritis: Improvements in Joint Pain and the Impact of Musculoskeletal Symptoms

Merola JF, Mease PJ, Armstrong AW, Strand V, Lehman T, Varga S, Choi JC, Becker B, Zhong Y, Colombo MJ, Thaçi D, Bili A, Gottlieb[...]